Publikationen 2022

Original- und Übersichtsarbeiten 2022

Zare M, Vehreschild MJGT, Wagenlehner F: Management of uncomplicated recurrent urinary tract infections. BJU Int. 129(6):668-678 (2022)

Wagenlehner FME, Dittmar F: Re: Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Eur Urol 81(2):213 (2022)

Bruyère F, Piraux A, Bohbot JM, Begue C, Vallée M, Alidjanov J, Pilatz A, Naber KG, Wagenlehner FME: Linguistic validation and cognitive assessment of the French version of the Acute Cystitis Symptom Score questionnaire. Prog Urol 32(2):73-76 (2022)

Magistro G, Stief CG, Wagenlehner FME, Pilatz A: [Urinary diversion for acute epididymitis : Transurethral or suprapubic catheter?. Urologie; 61(6):609-613 (2022)

Cai T, Gallelli L, Cione E, Verze P, Palmieri A, Mirone V, Bonkat G, Wagenlehner FM, Bjerklund Johansen TE: The efficacy and tolerability of pollen extract in combination with hyaluronic acid and vitamins in the management of patients affected by chronic prostatitis/chronic pelvic pain syndrome: a 26 weeks, randomized, controlled, single-blinded, phase III study. Minerva Urol Nephrol. 2022 Dec;74(6):780-788

Choi JB, Cho KJ, Han KH, Alidjanov JF, Pilatz AME, Wagenlehner FME, Naber KG, Choe HS, Lee SJ: Translation and validation of the Korean version of acute cystitis symptom score. Investig Clin Urol  63(2):221-227 (2022)

Cai T, Tamanini I, Collini L, Brugnolli A, Migno S, Mereu L, Tateo S, Pilatz A, Rizzo M, Liguori G, Bonkat G, Wagenlehner FME, Bjerklund Johansen TE: Management of Recurrent Cystitis in Women: When Prompt Identification of Risk Factors Might Make a Difference. Eur Urol Focus 5:S2405-4569 (2022)

Kranz J, Lackner J, Künzel U, Wagenlehner F, Schmidt S: Phytotherapy in Adults With Recurrent Uncomplicated Cystitis–a Systematic Review. Dtsch Arztebl Int 20;119(20):353-360 (2022)

Wagenlehner F, Nicolle L, Bartoletti R, Gales AC, Grigoryan L, Huang H, Hooton T, Lopardo G, Naber K, Poojary A, Stapleton A, Talan DA, Saucedo JT, Wilcox MH, Yamamoto S, Yang SS, Lee SJ: A global perspective on improving patient care in uncomplicated urinary tract infection: expert consensus and practical guidance. J Glob Antimicrob Resist 28:18-29 (2022)

Espey BT, Kielwein K, van der Ven H, Steger K, Allam JP, Paradowska-Dogan A, van der Ven K: Effects of Pulsed-Wave Photobiomodulation Therapy on Human Spermatozoa. Lasers Surg Med 54(4):540-553 (2022)

Kranz J, Stangl F, Kuppe C, Wagenlehner F, Saar M, Schneidewind L: Urosepsis-targeted diagnostics and effective therapy. Urologie 61(6):596-601 (2022)

Naber KG, Tirán-Saucedo J, Wagenlehner FME; RECAP group: Psychosocial burden of recurrent uncomplicated urinary tract infections. GMS Infect Dis 24;10: Doc01. eCollection (2022)

Groeger S, Wu F, Wagenlehner F, Dansranjav T, Ruf S, Denter F, Meyle J: PD-L1 Up-Regulation in Prostate Cancer Cells by Porphyromonas gingivalis. Front Cell Infect Microbiol 29;12:935806 (2022)

Kaußner Y, Röver C, Heinz J, Hummers E, Debray TPA, Hay AD, Heytens S, Vik I, Little P, Moore M, Stuart B, Wagenlehner F, Kronenberg A, Ferry S, Monsen T, Lindbæk M, Friede T, Gágyor I: Reducing antibiotic use in uncomplicated urinary tract infections in adult women: a systematic review and individual participant data meta-analysis. Clin Microbiol Infect 1: S1198-743X(22)00330-5 (2022)

Wagenlehner F, Lorenz H, Ewald O, Gerke P. Antibiotics (Basel): Why d-Mannose May Be as Efficient as Antibiotics in the Treatment of Acute Uncomplicated Lower Urinary Tract Infections-Preliminary Considerations and ConclusioPDns from a Non-Interventional Study 25;11(3):314 (2022)

Kranz J, Wiesinger CG, Nagler J, Pfuner J, Steffens J, Hüsch T, Wagenlehner FME, Schneidewind L: Comparative Analysis of Guideline Adherence between Germany and Austria by Using the Example of Uncomplicated Urinary Tract Infections. Urol Int 7:1-7 (2022)

Fritzenwanker M, Grabitz MO, Arneth B, Renz H, Imirzalioglu C, Chakraborty T, Wagenlehner F: Comparison of Urine Flow Cytometry on the UF-1000i System and Urine Culture of Urine Samples from Urological Patients. Urol Int 106(8):858-868 (2022)

Kresken M, Pfeifer Y, Wagenlehner F, Werner G, Wohlfarth E: Resistance to Mecillinam and Nine Other Antibiotics for Oral Use in Escherichia coli Isolated from Urine Specimens of Primary Care Patients in Germany, 2019/20. Therapy OBOSG'ROTPESFI Antibiotics (Basel) 31;11(6):751 (2022)

Rosellen J, Wagenlehner F: Tebipenem pivoxil : Oral carbapenem for treatment of complicated urinary tract infections. Urologie 61(7):775-776 (2022)

Stapleton AE, Wagenlehner FME, Mulgirigama A, Twynholm M: Erratum for Stapleton et al., "Escherichia coli Resistance to Fluoroquinolones in Community-Acquired Uncomplicated Urinary Tract Infection in Women: a Systematic Review". Antimicrob Agents Chemother 18;66(1):e0220921 (2022)

Schneidewind L, Stangl FP, Dräger DL, Wagenlehner FME, Hakenberg OW, Kranz J: What is the proportion of infectiology in the specialization urology? : A pilot study to underline the significance of Antibiotic Stewardship in urology. Urologie 13. doi: 10.1007/s00120-022-01898-1. Online ahead of print (2022)

Rosellen J, Diemer T, Hauptmann A, Wagenlehner F: Testosterone treatment. Urologie 61(11):1260-1275 (2022)

Schiereck T, Yeldan S, Kranz J, Schneidewind L, Wagenlehner F, Wieters I, Vehreschild MJGT, Otto T, Barski D. Urinary bladder microbiome analysis and probiotic treatment options for women with recurrent urinary tract infections. Urologe A. 2022 Jan;61(1):41-51 (2022)

Klußmann D, Wagenlehner F: What to do about recurrent urinary tract infections. Dtsch Med Wochenschr Sep;147(17):1140-1145 (2022)

Wagenlehner FME, Dittmar F: Re: Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis. Eur Urol Dec;82(6):658. doi: 10.1016 (2022)

Targeting Host Tyrosine Kinase Receptor EPHA2 Signaling Affects Uropathogen Infection in Human Bladder Epithelial Cells. Prakash PS, Kruse A, Vogel C, Schagdarsurengin U, Wagenlehner F: Pathogens. 12;11(10):1176 (2022)

Schagdarsurengin U, Breiding V, Loose M, Wagenlehner F, Dansranjav T: Interleukin-1 receptor associated kinase 1 (IRAK1) is epigenetically activated in luminal epithelial cells in prostate cancer. Front Oncol 26;12:991368, e-collection (2022)

Consensus Statement on Urinary Stone Treatment During a Pandemic: A Delphi Process from the Endourological Society TOWER Research Initiative. Scotland KB, Tailly T, Chew BH, Bhojani N, Smith D; TOWER Initiative. J Endourol 36(3):335-344 (2022)

Vahlensieck W, Heim S, Patz B, Sahin K: Beneficial effects of pumpkin seed soft extract on lower urinary tract symptoms and quality of life in men with benign prostatic hyperplasia: a meta-analysis of two randomized, placebo-controlled trials over 12 months

Clinical Phytoscience 2022; 8:13 (2022)

Nestler S, Peschel C, Horstmann AH, Vahlensieck W, Fabry W, Neisius A: Prospective multicentre randomized double-blind placebo-controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections. Int Urol Nephrol 10.1007/s11255-022-03379-y (2022)

Prostate Volume Influence on Postoperative Outcomes for Patients Undergoing RARP: A Monocentric Serial Analysis of 500 Cases.

Farzat M, Rosenbauer J, Tanislav C, Wagenlehner FM. J Clin Med. 2023 Mar 25;12(7):2491. doi: 10.3390/jcm12072491.

Validation of the Spanish Acute Cystitis Symptoms Score (ACSS) in native Spanish-speaking women of Europe and Latin America.

Medina-Polo J, Arrébola-Pajares A, Corrales-Riveros JG, Alidjanov JF, Lorenzo-Gómez MF, Tapia AH, Martínez-Berganza ML, Ospina-Galeano IA, Padilla-Fernández B, Pilatz A, Naber KG, Wagenlehner FM. Neurourol Urodyn. 2023 Jan;42(1):263-281. doi: 10.1002/nau.25079. Epub 2022 Nov 6. PMID: 36335613 Free PMC article.

Bilsen MP, Jongeneel RMH, Schneeberger C, Platteel TN, van Nieuwkoop C, Mody L, Caterino JM, Geerlings SE, Köves B, Wagenlehner F, Conroy SP, Visser LG, Lambregts MMC: Definitions of Urinary Tract Infection in Current Research: A Systematic Review. Open Forum Infect Dis. 27;10(7):ofad332 (2023)

Post-prostatic-massage urine exosomes of men with chronic prostatitis/chronic pelvic pain syndrome carry prostate-cancer-typical microRNAs and activate proto-oncogenes.

Schneider L, Dansranjav T, Neumann E, Yan H, Pilatz A, Schuppe HC, Wagenlehner F, Schagdarsurengin U. Mol Oncol. 2023 Mar;17(3):445-468. doi: 10.1002/1878-0261.13329.

Validation of the Spanish Acute Cystitis Symptoms Score (ACSS) in native Spanish-speaking women of Europe and Latin America.

Medina-Polo J, Arrébola-Pajares A, Corrales-Riveros JG, Alidjanov JF, Lorenzo-Gómez MF, Tapia AH, Martínez-Berganza ML, Ospina-Galeano IA, Padilla-Fernández B, Pilatz A, Naber KG, Wagenlehner FM. Neurourol Urodyn. 2023 Jan;42(1):263-281. doi: 10.1002/nau.25079. Epub 2022 Nov 6. PMID: 36335613 Free PMC article.

How May Longer Console Times Influence Outcomes after Robot-Assisted Radical Prostatectomy (RARP)? Farzat M, Elsherif M, Wagenlehner FM. J Clin Med. 2023 Jun 13;12(12):4022. doi: 10.3390/jcm12124022. PMID: 37373715 Free PMC article.

Farzat M, Sharabaty I, Tanislav C, Alsaid Y, Wagenlehner FM. J Clin Med. 2023 Jun 7;12(12):3908. doi: 10.3390/jcm12123908. PMID: 37373603 Free PMC article. METHODS: Five hundred patients from one referral center who underwent RARP between April 2019 and August 2022 were included in this retrospective study. To investigate the impact of patient BMI on postoperative outcomes, we divided our cohort into two groups with a cut-off …